PEPFAR success critically dependent on use of generic ARVs, study shows
It's conference countdown here at NAM and the office is a hive of activity
Welcome to the new aidsmap.com and welcome to our blog!
Merck stops development of CCR5 inhibitor vicriviroc
Maraviroc potentially useful if neurological disease is present
Towards more compassionate care for people with drug-resistant TB